DD201900A5 - Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen - Google Patents
Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen Download PDFInfo
- Publication number
- DD201900A5 DD201900A5 DD81234718A DD23471881A DD201900A5 DD 201900 A5 DD201900 A5 DD 201900A5 DD 81234718 A DD81234718 A DD 81234718A DD 23471881 A DD23471881 A DD 23471881A DD 201900 A5 DD201900 A5 DD 201900A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- alkyl
- different
- radical
- chain
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19803042769 DE3042769A1 (de) | 1980-11-13 | 1980-11-13 | C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
DD201900A5 true DD201900A5 (de) | 1983-08-17 |
Family
ID=6116648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD81234718A DD201900A5 (de) | 1980-11-13 | 1981-11-09 | Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0052300B1 (da) |
JP (1) | JPS57109766A (da) |
AT (1) | ATE11773T1 (da) |
AU (1) | AU546605B2 (da) |
CA (1) | CA1179342A (da) |
DD (1) | DD201900A5 (da) |
DE (2) | DE3042769A1 (da) |
DK (1) | DK501881A (da) |
ES (3) | ES507080A0 (da) |
FI (1) | FI813567L (da) |
GR (1) | GR76338B (da) |
HU (1) | HU186438B (da) |
IL (1) | IL64253A (da) |
NO (1) | NO813649L (da) |
PT (1) | PT73920B (da) |
ZA (1) | ZA817840B (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3208628A1 (de) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
EP0094159B1 (en) * | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dihydropyridine derivatives, their production and use |
US4656181A (en) * | 1982-11-24 | 1987-04-07 | Cermol S.A. | Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same |
EP0145956A1 (de) * | 1983-11-16 | 1985-06-26 | Ciba-Geigy Ag | Neue Amid-Verbindungen |
JPS60120861A (ja) * | 1983-12-02 | 1985-06-28 | Otsuka Pharmaceut Co Ltd | ジヒドロピリジン誘導体 |
US4672068A (en) * | 1984-05-04 | 1987-06-09 | Fujirebio Kabushiki Kaisha | Antihypertensive 1,4-dihydropyridines having a conjugated ester |
US4757071A (en) * | 1984-12-14 | 1988-07-12 | Nisshin Flour Milling Co., Ltd. | 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases |
IT1203900B (it) * | 1987-04-15 | 1989-02-23 | Lagor Spa | Poli 1,4-diidro-2,6-dimetilpiridine 3,5-dicarbossilesteri utili come stabilizzanti termici per polimeri sintetici |
IL91382A (en) * | 1988-09-01 | 1995-06-29 | Orion Yhtymae Oy | Dicitons are converted into alkanyl or ethylmethylene, through their preparation and pharmaceutical preparations containing them |
US5185370A (en) * | 1988-09-01 | 1993-02-09 | Orion-Yhtyma Oy | Substituted β-diketones and their use |
GB9002337D0 (en) * | 1990-02-02 | 1990-04-04 | Orion Yhtymae Oy | Compounds useful in treating inflammatory bowel disease |
US6897305B2 (en) | 1998-06-08 | 2005-05-24 | Theravance, Inc. | Calcium channel drugs and uses |
CA2318901A1 (en) * | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Novel calcium channel drugs and uses |
US7101909B2 (en) | 1998-10-12 | 2006-09-05 | Theravance, Inc. | Calcium channel drugs and uses |
GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1795788A1 (de) * | 1966-11-16 | 1975-07-31 | Astra Ab | Pyridinderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel |
DE2117571C3 (de) * | 1971-04-10 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
DE2847236A1 (de) * | 1978-10-31 | 1980-05-14 | Bayer Ag | Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1980
- 1980-11-13 DE DE19803042769 patent/DE3042769A1/de not_active Withdrawn
-
1981
- 1981-10-28 NO NO813649A patent/NO813649L/no unknown
- 1981-10-31 AT AT81109456T patent/ATE11773T1/de not_active IP Right Cessation
- 1981-10-31 DE DE8181109456T patent/DE3168955D1/de not_active Expired
- 1981-10-31 EP EP81109456A patent/EP0052300B1/de not_active Expired
- 1981-11-03 PT PT73920A patent/PT73920B/pt unknown
- 1981-11-05 AU AU77110/81A patent/AU546605B2/en not_active Ceased
- 1981-11-09 DD DD81234718A patent/DD201900A5/de unknown
- 1981-11-10 IL IL64253A patent/IL64253A/xx unknown
- 1981-11-10 CA CA000389828A patent/CA1179342A/en not_active Expired
- 1981-11-11 FI FI813567A patent/FI813567L/fi not_active Application Discontinuation
- 1981-11-11 GR GR66490A patent/GR76338B/el unknown
- 1981-11-12 ZA ZA817840A patent/ZA817840B/xx unknown
- 1981-11-12 DK DK501881A patent/DK501881A/da unknown
- 1981-11-12 JP JP56180437A patent/JPS57109766A/ja active Pending
- 1981-11-12 ES ES507080A patent/ES507080A0/es active Granted
- 1981-11-13 HU HU813401A patent/HU186438B/hu unknown
-
1982
- 1982-03-09 ES ES510254A patent/ES510254A0/es active Granted
- 1982-03-09 ES ES510253A patent/ES510253A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
DK501881A (da) | 1982-05-14 |
HU186438B (en) | 1985-07-29 |
PT73920A (en) | 1981-12-01 |
EP0052300B1 (de) | 1985-02-13 |
FI813567L (fi) | 1982-05-14 |
JPS57109766A (en) | 1982-07-08 |
CA1179342A (en) | 1984-12-11 |
AU7711081A (en) | 1982-05-20 |
ES8303337A1 (es) | 1983-02-01 |
ZA817840B (en) | 1982-10-27 |
IL64253A (en) | 1985-03-31 |
DE3042769A1 (de) | 1982-06-09 |
GR76338B (da) | 1984-08-04 |
PT73920B (en) | 1983-03-29 |
ES8206477A1 (es) | 1982-08-16 |
NO813649L (no) | 1982-05-14 |
IL64253A0 (en) | 1982-02-28 |
ES507080A0 (es) | 1982-08-16 |
ES510254A0 (es) | 1983-02-01 |
ATE11773T1 (de) | 1985-02-15 |
AU546605B2 (en) | 1985-09-12 |
ES8303336A1 (es) | 1983-02-01 |
DE3168955D1 (en) | 1985-03-28 |
EP0052300A1 (de) | 1982-05-26 |
ES510253A0 (es) | 1983-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0012180B1 (de) | Neue 1,4-Dihydropyridinverbindungen, Verfahren zu ihrer Herstellung, die genannten Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel | |
EP0088274B1 (de) | Neue 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihrer Verwendung in Arzneimitteln | |
EP0088276B1 (de) | Neue Verbindungen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
EP0071819B2 (de) | Dihydropyridine mit positiv inotroper Wirkung, neue Verbindungen, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung | |
EP0011706B1 (de) | Verfahren zur Herstellung von teilweise neuen 1,4-Dihydropyridin-3-carbonsäure-Derivaten (I), neue 1,4-Dihydropyridin-3-carbonsäure-Derivate (II) und die Verwendung der Derivate (I) und (II) zur Herstellung von 1,4-Dihydropyridin-3,5-dicarbonsäurediestern | |
EP0002208B1 (de) | Nitrosubstituierte 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie deren Herstellung | |
DE2935451A1 (de) | Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel | |
DD201900A5 (de) | Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen | |
EP0009206A2 (de) | Fluorhaltige 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung | |
EP0001769A1 (de) | 1,4-Dihydropyridincarbonsäureester mit schwefelhaltigen Estergruppen, ihre Herstellung und ihre Verwendung als Arzneimittel | |
EP0039863B1 (de) | 1,4-Dihydropyridine mit unterschiedlichen Substituenten in 2- und 6-Position, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
CH634053A5 (de) | Verfahren zur herstellung neuer aminoalkylidenamino-1.4-dihydropyridine. | |
DE3209276A1 (de) | Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung | |
DE2658804A1 (de) | Kreislaufbeeinflussende mittel | |
EP0110259A1 (de) | 1,4-Dihydropyridinderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln | |
DE3209274A1 (de) | Pyridincarbonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
DE2847237A1 (de) | Verfahren zur herstellung von 1,4-dihydropyridincarbonsaeuren sowie ihre verwendung als arzneimittel | |
CH633265A5 (de) | Verfahren zur herstellung des neuen 1.4-dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsaeure-isopropyl-(2-propoxy-aethyl)-esters. | |
DE2639498A1 (de) | Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
DE2616991A1 (de) | Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
EP0167068B1 (de) | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3,5-dicarbonsäure-isopropyl-[2-(3-trifluormethylphenoxy)-ethyl]-ester, mehrere Verfahren zu seiner Herstellung sowie seine Verwendung in Arzneimitteln | |
EP0225574A1 (de) | Neue, fluorhaltige 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
DE3501855A1 (de) | 5-aryl-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln | |
DE3023821A1 (de) | 4,4-disubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln | |
EP0199238A1 (de) | 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln |